Kumquat Biosciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $30M

  • Investors
  • 8

Kumquat Biosciences General Information

Description

Developer of small molecule oncology therapeutics designed to address cancer treatment resistance. The company's platform develops KRAS-targeted therapies, combination treatment candidates, immune modulation approaches, and clinical-stage oncology programs, enabling biotechnology companies, researchers, and healthcare providers to improve outcomes for patients with difficult-to-treat cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10770 Wateridge Circle
  • Suite 120
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 10770 Wateridge Circle
  • Suite 120
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kumquat Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A2) 16-Aug-2021 $30M Completed Pre-Clinical Trials
2. Early Stage VC (Series A1) 16-Feb-2021 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 08-Sep-2019 $55.9M $55.9M Completed Startup
To view Kumquat Biosciences’s complete valuation and funding history, request access »

Kumquat Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Series A 20,489,018 $0.001000 $2.73 $2.73 1x $2.73 44.07%
To view Kumquat Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kumquat Biosciences Patents

Kumquat Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026236375-A1 Bifunctional compounds useful as ras protein degraders Pending 07-May-2025
WO-2026236340-A1 Methods of modulating cell proliferation Pending 07-May-2025
WO-2026193007-A1 Heterocyclic compounds and uses thereof Pending 10-Mar-2025
WO-2026193011-A1 Heterocyclic compounds and uses thereof Pending 10-Mar-2025
WO-2026112350-A1 Heterocyclic compounds and uses thereof Pending 22-Nov-2024 A61K40/31
To view Kumquat Biosciences’s complete patent history, request access »

Kumquat Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kumquat Biosciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sequoia Capital Venture Capital Minority
Boxer Capital Corporate Venture Capital Minority
Codon Capital Venture Capital Minority
EcoR1 Capital Venture Capital Minority
HSG (Hong Kong) Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Kumquat Biosciences FAQs

  • When was Kumquat Biosciences founded?

    Kumquat Biosciences was founded in 2019.

  • Where is Kumquat Biosciences headquartered?

    Kumquat Biosciences is headquartered in San Diego, CA.

  • What is the size of Kumquat Biosciences?

    Kumquat Biosciences has 45 total employees.

  • What industry is Kumquat Biosciences in?

    Kumquat Biosciences’s primary industry is Drug Discovery.

  • Is Kumquat Biosciences a private or public company?

    Kumquat Biosciences is a Private company.

  • What is the current valuation of Kumquat Biosciences?

    The current valuation of Kumquat Biosciences is .

  • What is Kumquat Biosciences’s current revenue?

    The current revenue for Kumquat Biosciences is .

  • How much funding has Kumquat Biosciences raised over time?

    Kumquat Biosciences has raised $136M.

  • Who are Kumquat Biosciences’s investors?

    Sequoia Capital, Boxer Capital, Codon Capital, EcoR1 Capital, and HSG (Hong Kong) are 5 of 8 investors who have invested in Kumquat Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process